Early research (Phase 1)Study completedNCT00288431
What this trial is testing
Safety, Tolerability and Maximum Tolerated Dose of Oral AP23573 in Combination With Doxorubicin (8669-015)
Who this might be right for
CancerSarcoma
Merck Sharp & Dohme LLC 37